Ken Griffin Sol Gel Technologies Ltd. Put Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Put Options
3 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
7.34MCall Options Held
5.4KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.63 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.03MShares$1.34 Million0.02% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$810,1810.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$607,4190.02% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$151,2570.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $15.3M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...